No Data
Piper Sandler Maintains Zura Bio(ZURA.US) With Buy Rating, Maintains Target Price $26
Analysts Conflicted on These Healthcare Names: Zura Bio (ZURA), Insmed (INSM) and Harmony Biosciences Holdings (HRMY)
Analyst Sees Multi-Billion-Dollar Sales Potential for Zura Bio's Lead Therapy
William Blair Initiates Zura Bio(ZURA.US) With Buy Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: Qiagen (QGEN) and Zura Bio (ZURA)
Express News | Wedbush Reiterates Outperform on Zura Bio, Maintains $15 Price Target